Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Mar;98(12):e14921.
doi: 10.1097/MD.0000000000014921.

Late adverse effects related to treatment in a cohort of survivors of childhood and adolescent cancer

Annemeri Livinalli  1 , Marcus Tolentino Silva, Luciane Cruz Lopes
Affiliations
Randomized Controlled Trial

Late adverse effects related to treatment in a cohort of survivors of childhood and adolescent cancer

Annemeri Livinalli et al. Medicine (Baltimore). 2019 Mar.

Abstract

Taking into consideration the progress in cancer treatment, an increase in the number of adult survivors of childhood cancer is expected. These survivors will have received treatment that predisposes them to late morbidity and increased risk of early mortality. The aim of this single-center retrospective cohort study was to describe the frequency and identify risk factors associated with late adverse events related to cancer treatment in survivors of childhood and adolescent cancer.Patients were recruited from 2010 to 2014. All possible late adverse effects identified, were classified according to CTCAE grading system version 4.0. The variables were characterized and stratified according to the presence or not of late effects. Odds ratio was used as a measure of association in bivariate analysis to identify characteristics associated with the late effects of treatment. Among 111 potentially eligible participants, 62 survivors met the inclusion criteria; 17 (27.4%) had abnormal test results observed in the systems: 8 (47%) in the endocrine and metabolic, 7 (41.2%) in the cardiovascular, 5 (29.4%) in the musculoskeletal, and 1 (5.9%) in auditory and renal systems. Frequency and severity of late adverse events were not affected by treatments employed; except for radiotherapy which was associated with a higher risk of late adverse effect occurrences.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Sample composition flowchart. LAE = late adverse effects, VER = Living the Hope of Restarting.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Brasil, Ministério da Saúde. Estimativa 2018: incidência de câncer no Brasil. Instituto Nacional de Câncer José Alencar Gomes da Silva, Coordenação de Prevenção e Vigilância—Rio de Janeiro—INCA, 2017. Available at: http://www.inca.gov.br/estimativa/2018/ [access date July 30, 2018].
    1. Phillips SM, Padgett LS, Leisenring WM, et al. Survivors of childhood cancer in the United States: prevalence and burden of morbidity. Cancer Epidem Biomarkers Prev 2015;24:653–63. - PMC - PubMed
    1. Hjorth L, Haupt R, Skinner R, et al. Survivorship after childhood cancer: PanCare: a European network to promote optimal long-term care. Eur J Cancer 2015;51:1203–11. - PMC - PubMed
    1. Dickerman JD. The late effects of childhood cancer therapy. Pediatrics 2007;119:554–68. - PubMed
    1. Armstrong GT, Liu Q, Yasui Y, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the childhood cancer survivor study. J Clin Oncol 2009;27:2328–38. - PMC - PubMed

Publication types

Substances